OOIR: Observatory of International Research

Papers

(The H4-Index of Schizophrenia Research is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	162
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	101
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	92
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data	83
Early cognitive development and psychopathology in children at familial high risk for schizophrenia	73
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 2017	67
Meta-analysis of a family history of diabetes in schizophrenia	62
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	51
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	48
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective	47
Frequency of clinical appointments in subjects with emergent suicidal ideation	47
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	45
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	43
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	43
Issue Highlights	42
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?	42
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia	41
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems	39
Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia	37
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	37
The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study	37
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans	36
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	35
Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis	35
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	35

Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital	34
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis	34
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction	34
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	33
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	32
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	31